Skip to search formSkip to main contentSkip to account menu

Adjunct Agent

In cancer therapy, a drug or substance used in addition to the primary therapy.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Novel synthesis of magnetic nanoparticles conjugation with Perfluorocarbon Nano-bubbles for potential adjunct therapy of acute myocardial ischemia
Introduction. The study was performed in search of a novel adjunct agent for myocardial salvage in acute myocardial ischemia… 
Review
2018
Review
2018
Intravitreal Dexamethasone Implant in the Treatment of Non-Infectious Uveitic Macular Edema
Macular Edema (ME) is a common complication, leading to severe vision loss in patients with Non-Infectious Uveitis (NIU). The… 
2017
2017
Surgical Management with Adjunct Electrochemotherapy for Fibrosarcoma in a Horse
2016
2016
Postdischarge complications following nonoperative management of blunt splenic injury.
Review
2013
Review
2013
FRI0339 Systematic review of drug trials in the treatment of giant cell arteritis.
Background Giant cell arteritis is the most common vasculitis in individuals aged greater than 50yrs in the western world and has… 
Review
2012
Review
2012
Dietary Supplementations as Neuroprotective Therapies: Focus on NT-020 Diet Benefits in a Rat Model of Stroke
Stroke remains the number one cause of disability in the adult population. Despite scientific progress in our understanding of… 
2011
2011
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Reduction in low-density lipoprotein cholesterol (LDL-C) decreases the burden of coronary artery disease. The 3-hydroxy-3… 
Review
2004
Review
2004
NXY‐059: A neuroprotective agent in acute stroke
Free radicals play an important role in secondary processes in ischaemic brain injury. Disodium 4‐[(tert‐butylimino) methyl… 
1985
1985
Niridazole as an adjunct to "conventional" immunosuppression in kidney allograft transplantation. Long-term follow up.
To assess the value of niridazole as adjuvant immunosuppressant to conventional steroid and azathioprine therapy, a prospective… 
1966
1966
Letter to the editor
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)